- Effectiveness and safety of tofacitinib in rheumatoid arthritis: A cohort study
- Venetoclax–rituximab in relapsed or refractory chronic lymphocytic leukemia
- Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing reconstructive pelvic surgery
- Siponimod vs placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study
- <em>Acinetobacter baumannii</em> resistance trends in children in the United States, 1999–2012
- Attributable risk and time course of colistin-associated acute kidney injury
- Nivolumab plus ipilimumab vs sunitinib in advanced renal-cell carcinoma
- Systematic review and meta-analysis to assess the safety of buproprion and varenicline in pregnancy
- Personalized statin therapy and coronary atherosclerotic plaque burden in asymptomatic low/intermediate-risk individuals
- Encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): A multicentre, open-label, randomised phase 3 trial
- Computerised training improves cognitive performance in chronic pain: A participant-blinded randomised active-controlled trial with remote supervision
- Prognostic impact of missed chemotherapy doses during chemoradiation therapy for non–small cell lung cancer
- Insulin glargine combined with oral antidiabetic drugs for Asians with type 2 diabetes mellitus: A pooled analysis to identify predictors of dose and treatment response
- Efficacy, safety, and potential biomarkers of sunitinib and transarterial chemoembolization (TACE) combination in advanced hepatocellular carcinoma (HCC): Phase II trial
- Early-stage uterine pure and mixed clear cell carcinoma: Outcomes and recurrence with and without adjuvant therapy
Feed Sources
